Terms: = Sarcomas AND PR, PGR, progesterone receptor
837 results:
1. Primary pulmonary histiocytic sarcoma with high PD-L1 expression benefited from immunotherapy: A case report and bioinformatic analysis.
Lin Y; Cao Q; Hong A; Liang X
Clin Respir J; 2024 Mar; 18(3):e13741. PubMed ID: 38450981
[TBL] [Abstract] [Full Text] [Related]
2. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
3. Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study.
Rask G; Wadsten C; Acs B; Hartman J; Fredriksson I; Garmo H; Wärnberg F; Sund M
Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38395442
[TBL] [Abstract] [Full Text] [Related]
4. Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
Sholler GLS; Bergendahl G; Lewis EC; Kraveka J; Ferguson W; Nagulapally AB; Dykema K; Brown VI; Isakoff MS; Junewick J; Mitchell D; Rawwas J; Roberts W; Eslin D; Oesterheld J; Wada RK; Pastakia D; Harrod V; Ginn K; Saab R; Bielamowicz K; Glover J; Chang E; Hanna GK; Enriquez D; Izatt T; Halperin RF; Moore A; Byron SA; Hendricks WPD; Trent JM
Genome Med; 2024 Feb; 16(1):28. PubMed ID: 38347552
[TBL] [Abstract] [Full Text] [Related]
5. Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunotherapy efficacy.
Zhou P; Fu Y; Tang Y; Jiang L; Wang W
Lung Cancer; 2024 Mar; 189():107471. PubMed ID: 38306886
[TBL] [Abstract] [Full Text] [Related]
6. First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Piha-Paul SA; Xu B; Dumbrava EE; Fu S; Karp DD; Meric-Bernstam F; Hong DS; Rodon JA; Tsimberidou AM; Raghav K; Ajani JA; Conley AP; Mott F; Fan Y; Fan J; Peng P; Wang H; Ni S; Sun C; Qiang X; Levin WJ; Ngo B; Ru QC; Wu F; Javle MM
Oncologist; 2024 Apr; 29(4):e514-e525. PubMed ID: 38297981
[TBL] [Abstract] [Full Text] [Related]
7. Targeted Therapy and Immunotherapy for Advanced Malignant Conjunctival Tumors: Systematic Review.
Serbest Ceylanoglu K; Guneri Beser B; Singalavanija T; Juntipwong S; Worden FP; Demirci H
Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):18-29. PubMed ID: 38241616
[TBL] [Abstract] [Full Text] [Related]
8. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract] [Full Text] [Related]
10. Malignant female genital tract smooth muscle tumors with adipocytic differentiation: A morphologic, immunohistochemical, MDM2 fluorescence in situ hybridization and molecular genetic study of 6 lipoleiomyosarcomas.
Swanson AA; Michal M; Xing D; Dashti NK; Židlík V; Cheek-Norgan EH; Keeney ME; Keeney GL; Sukov WR; Gupta S; Nucci MR; Schoolmeester JK
Hum Pathol; 2024 Jan; 143():24-32. PubMed ID: 38000678
[TBL] [Abstract] [Full Text] [Related]
11. Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma.
Hwang JR; Cho YJ; Ryu JY; Choi JY; Choi JJ; Sa JK; Kim HS; Lee JW
Biomed Pharmacother; 2023 Dec; 168():115792. PubMed ID: 37924789
[TBL] [Abstract] [Full Text] [Related]
12. Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical study.
Stacchiotti S; Baldi GG; Frezza AM; Morosi C; Greco FG; Collini P; Barisella M; Dagrada GP; Zaffaroni N; Pasquali S; Gronchi A; Huang P; Ingrosso M; Tinè G; Miceli R; Casali PG
Eur J Cancer; 2023 Dec; 195():113391. PubMed ID: 37918286
[TBL] [Abstract] [Full Text] [Related]
13. Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.
Maekawa N; Konnai S; Hosoya K; Kim S; Kinoshita R; Deguchi T; Owaki R; Tachibana Y; Yokokawa M; Takeuchi H; Kagawa Y; Takagi S; Ohta H; Kato Y; Yamamoto S; Yamamoto K; Suzuki Y; Okagawa T; Murata S; Ohashi K
PLoS One; 2023; 18(10):e0291727. PubMed ID: 37792729
[TBL] [Abstract] [Full Text] [Related]
14. Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic follicular dendritic cell sarcoma of the spleen: a case report.
Li J; Ren M; Bi F; Chen Y; Li Z
Front Immunol; 2023; 14():1228653. PubMed ID: 37691960
[TBL] [Abstract] [Full Text] [Related]
15. A multicenter retrospective analysis of clinical outcomes of intracranial chondrosarcoma in 26 patients.
Liu H; Li Z; Xue Y; Zhao T; Wu Y
Sci Rep; 2023 Sep; 13(1):14647. PubMed ID: 37669996
[TBL] [Abstract] [Full Text] [Related]
16. ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature.
Zhao L; Cheng YW; Policarpio-Nicolas MLC
Int J Gynecol Pathol; 2023 Nov; 42(6):597-601. PubMed ID: 37562066
[TBL] [Abstract] [Full Text] [Related]
17. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
[TBL] [Abstract] [Full Text] [Related]
18. Case Report: Immunotherapy for low-grade myofibroblastic sarcoma of the pharynx.
Sun B; Luo Z; Liu P; He Y; He S; Liu W
Front Immunol; 2023; 14():1190210. PubMed ID: 37469511
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy and safety of vilaprisan in women with uterine fibroids: data from the ASTEROID 3 randomized controlled trial.
Al-Hendy A; Zhou YF; Faustmann T; Groettrup-Wolfers E; Laapas K; Parke S; Seitz C
F S Sci; 2023 Nov; 4(4):317-326. PubMed ID: 37437885
[TBL] [Abstract] [Full Text] [Related]
20. Intrathoracic synovial sarcoma with BRAF V600E mutation.
Russo I; Barresi S; Di Paolo PL; Di Ruscio V; Del Baldo G; Serra A; Vallese S; Miele E; Mastronuzzi A; Alaggio R; Ferrari A; Milano GM
Oncotarget; 2023 Jul; 14():703-708. PubMed ID: 37417899
[TBL] [Abstract] [Full Text] [Related]
[Next]
